Clinical Trial News and Research

RSS

Natural tissue graft can spur regeneration of cartilage; improves symptoms in knee cartilage damaged patients

A natural tissue graft can spur regeneration of cartilage and improve symptoms in patients who have cartilage damage in their knee, according to a study by researchers from Hospital for Special Surgery.

15 Jul 2013

Clinical trial begins on ultrasound in combination with tPA to treat acute ischemic stroke

An international, Phase III clinical trial studying ultrasound in combination with a clot-busting medication to treat acute ischemic stroke has begun at The University of Texas Health Science Center at Houston (UTHealth).

12 Jul 2013

Seattle Children's leukemia patient has positive response to T-cell therapy

The first patient in a cellular immunotherapy Phase 1 cancer trial at Seattle Children's has had a positive response to T-cell therapy. The 23-year-old patient, Lynsie Conradi, from Bellingham, Wash. received the welcome news yesterday.

12 Jul 2013

New noninvasive technique for tracking stem cells after transplantation

A new, noninvasive technique for tracking stem cells after transplantation - developed by a cross-disciplinary team of radiologists, chemists, statisticians and materials scientists at the Stanford University School of Medicine - could help surgeons determine whether a procedure to repair injured or worn-out knees is successful.

12 Jul 2013

Antibodies boost immune system to fight childhood cancer, shows study

Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4. Each of these antibodies binds to a different target molecule in the immune system, potentially heightening the body's own immune response to cancer.

12 Jul 2013

PathoQuest closes new fundraising of EUR 3.8 million

PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.

12 Jul 2013

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

Auspex Pharmaceuticals announced today that the first patient has been enrolled in a multi-center Phase 3 pivotal trial of its lead investigational drug, SD-809 for the treatment of involuntary movements (chorea) associated with Huntington's Disease.

12 Jul 2013

London research fellow says clinical study reports and trial results should be shared publicly

Ben Goldacre, research fellow at the London School of Hygiene and Tropical Medicine, says we need all the evidence to make informed decisions about medicines.

12 Jul 2013

New report says most psychological intervention studies do not account for placebo effect

Many brain-training companies tout the scientific backing of their products - the laboratory studies that reveal how their programs improve your brainpower. But according to a new report, most intervention studies like these have a critical flaw: They do not adequately account for the placebo effect.

12 Jul 2013

Medicare to propose new doctor payment for managing multiple chronic conditions

Medicare is proposing paying doctors for managing Medicare patients with multiple chronic conditions starting in 2015. In the meantime, a Medicare plan to deny an Eli Lily diagnostic test to patients unless they are enrolled in a clinical trial is decried by some Alzheimer's treatment advocates.

11 Jul 2013

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.

11 Jul 2013

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

The Nebraska Neuroscience Alliance at the University of Nebraska Medical Center, is embarking on a translational clinical trial using Leukine, a drug used to boost the immune system in cancer patients, to test a unique immune therapy in people with Parkinson's disease.

11 Jul 2013

Ohr Pharmaceutical enrolls first 60 patients in OHR-002 Phase II clinical trial for wet-AMD treatment

Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.

10 Jul 2013

Curetis starts prospective clinical trial for Unyvero P50 pneumonia application

Curetis AG today announced the start of an additional prospective, multicenter clinical trial of its marketed Unyvero™ P50 Pneumonia Application to demonstrate its clinical and health economic value.

10 Jul 2013

Innovative vaccine could offer hope to patients with advanced ovarian cancer

Loyola University Medical Center is conducting a clinical trial of an innovative vaccine that could offer hope to patients with advanced ovarian cancer.

10 Jul 2013

Study shows rates of brain loss caused by aging and AD are higher for women

The rates of regional brain loss and cognitive decline caused by aging and the early stages of Alzheimer's disease (AD) are higher for women and for people with a key genetic risk factor for AD, say researchers at the University of California, San Diego School of Medicine in a study published online July 4 in the American Journal of Neuroradiology.

10 Jul 2013

Low vitamin D blood levels associated with greater risk of heart disease varies by race, ethnicity

Low vitamin D blood levels are linked to greater risk of heart disease in whites and Chinese, but not in blacks and Hispanics, according to a study appearing this week in JAMA, a journal published by the American Medical Association.

10 Jul 2013

Kessler Foundation scientists receive more than $1.2 M grants from NJ Commission for SCI research

The New Jersey Commission on Spinal Cord Injury Research awarded three grants to scientists at Kessler Foundation. The grants, which exceed $1.2 million, fund studies of assisted walking with Ekso, the impact of aging in the population with spinal cord injury (SCI) and the effects of electrical stimulation on bone loss.

10 Jul 2013

Cancer immunotherapies promise to be a new tool in fight against cancer

Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.

9 Jul 2013

PHT announces availability of LogPad App System for clinical trial patients

PHT Corporation announced the general availability of the LogPad App™ System that collects compliant patient data using Apple and Android smartphones. The LogPad App gives sponsors and CROs the flexibility to deploy Phase II, III, and IV clinical studies plus post market and observational research to massive patient populations.

9 Jul 2013

Clinical Trial News and Research

Natural tissue graft can spur regeneration of cartilage; improves symptoms in knee cartilage damaged patients

Clinical trial begins on ultrasound in combination with tPA to treat acute ischemic stroke

Seattle Children's leukemia patient has positive response to T-cell therapy

New noninvasive technique for tracking stem cells after transplantation

Antibodies boost immune system to fight childhood cancer, shows study

PathoQuest closes new fundraising of EUR 3.8 million

Auspex enrolls first patient in SD-809 Phase 3 trial for treatment of chorea associated with HD

London research fellow says clinical study reports and trial results should be shared publicly

New report says most psychological intervention studies do not account for placebo effect

Medicare to propose new doctor payment for managing multiple chronic conditions

Bristol-Myers Squibb, Pfizer announce FDA acceptance of Eliquis sNDA for review

UNMC conducts clinical trial on Leukine to test unique immune therapy in people with Parkinson's

Ohr Pharmaceutical enrolls first 60 patients in OHR-002 Phase II clinical trial for wet-AMD treatment

Curetis starts prospective clinical trial for Unyvero P50 pneumonia application

Innovative vaccine could offer hope to patients with advanced ovarian cancer

Study shows rates of brain loss caused by aging and AD are higher for women

Low vitamin D blood levels associated with greater risk of heart disease varies by race, ethnicity

Kessler Foundation scientists receive more than $1.2 M grants from NJ Commission for SCI research

Cancer immunotherapies promise to be a new tool in fight against cancer

PHT announces availability of LogPad App System for clinical trial patients

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer